IDEXX Laboratories, Inc. (IDXX) key performance indicators and operating metrics (77 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| CAG Diagnostics Recurring Revenue | 974.71M | FY2026-Q2 |
| CAG Diagnostics recurring revenue growth (organic) | 10.00 percent | FY2026-Q2 |
| Operating Profit | 426M | FY2026-Q2 |
| Global premium instrument installed base growth | 12.00 percent | FY2026-Q1 |
| International CAG diagnostic recurring revenue (organic growth) | 9.50 percent | FY2026-Q2 |
| CAG Diagnostics recurring revenue growth - international | 15.00 percent | FY2026-Q2 |
| CAG Diagnostics recurring revenue growth (as reported) | 11.00 percent | FY2026-Q2 |
| IDEXX inVue Dx placements | 1.6K | FY2026-Q2 |
| CAG Diagnostics recurring revenue growth - U.S. | 10.00 percent | FY2026-Q2 |
| CAG Diagnostics recurring revenue growth - International (organic) | 12.00 percent | FY2026-Q2 |
| Catalyst Premium Instrument Placements WW | 1.34K | FY2026-Q2 |
| Total Premium Instrument Placements WW | 5.27K | FY2026-Q2 |
| CAG Diagnostics recurring revenue growth - International (as reported) | 14.00 percent | FY2026-Q2 |
| Operating expense growth (as reported) | 10.00 percent | FY2026-Q2 |
Back to IDXX overview · IDXX earnings · IDXX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.